InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Berger Mark Stanley. Director active across 1 company, notably Genprex, Inc.. Aggregated, 7 filings have been recorded. History available since 18 February 2023. The latest transaction was filed on 27 February 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations
Berger Mark Stanley is Chief Medical Officer at Genprex, Inc. He has 7 filings in total. In the 7 recent sampled filings available, the period runs from 2023-02-22 to 2026-02-27, with buy and sell amounts of 0 EUR and 0 EUR, and the most frequent transaction nature is Tax withholding.